Cargando…
β-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between β-arrestin2 and STAT3 in mouse model of depression
BACKGROUND: Major depressive disorder (MDD) is a prevalent and devastating psychiatric illness. Unfortunately, the current therapeutic practice, generally depending on the serotonergic system for drug treatment is unsatisfactory and shows intractable side effects. Multiple evidence suggests that dop...
Autores principales: | Liu, Yang, Song, Nanshan, Yao, Hang, Jiang, Siyuan, Wang, Yueping, Zheng, Ying, Zhou, Yuanzhang, Ding, Jianhua, Hu, Gang, Lu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526944/ https://www.ncbi.nlm.nih.gov/pubmed/36183107 http://dx.doi.org/10.1186/s12974-022-02597-6 |
Ejemplares similares
-
The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013) -
α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes
por: Du, Ren-Hong, et al.
Publicado: (2018) -
β-Arrestin–Biased Angiotensin II Receptor Agonists for COVID-19
por: Manglik, Aashish, et al.
Publicado: (2020) -
LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1
por: Rodriguiz, Ramona M., et al.
Publicado: (2021) -
Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)